Gene · 6839
Papers3,037
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,661 to 1,680 of 3,037
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS. | Cancer Cell | 2018 | 29478914 | PubTator, text mining | PubMed |
| E4BP4/NFIL3 modulates the epigenetically repressed RAS effector RASSF8 function through histone methyltransferases. | J Biol Chem | 2018 | 29467226 | PubTator, text mining | PubMed |
| UHRF1 regulates CDH1 via promoter associated non-coding RNAs in prostate cancer cells. | Biochim Biophys Acta Gene Regul Mech | 2018 | 29466696 | PubTator, text mining | PubMed |
| Altered gene expression profiles of histone lysine methyltransferases and demethylases in rheumatoid arthritis synovial fibroblasts. | Clin Exp Rheumatol | 2018 | 29465369 | PubTator, text mining | PubMed |
| SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter. | Cancer Lett | 2018 | 29458143 | PubTator, text mining | PubMed |
| Expression profiling of chromatin-modifying enzymes and global DNA methylation in CD4+ T cells from patients with chronic HIV infection at different HIV control and progression states. | Clin Epigenetics | 2018 | 29449904 | PubTator, text mining | PubMed |
| Norisoboldine, a natural AhR agonist, promotes Treg differentiation and attenuates colitis via targeting glycolysis and subsequent NAD+/SIRT1/SUV39H1/H3K9me3 signaling pathway. | Cell Death Dis | 2018 | 29449535 | PubTator, text mining | PubMed |
| Dynamic changes of SETD2, a histone H3K36 methyltransferase, in porcine oocytes, IVF and SCNT embryos. | PLoS One | 2018 | 29447173 | PubTator, text mining | PubMed |
| Epigenetic regulation of HIV-1 latency: focus on polycomb group (PcG) proteins. | Clin Epigenetics | 2018 | 29441145 | PubTator, text mining | PubMed |
| Resistance-promoting effects of ependymoma treatment revealed through genomic analysis of multiple recurrences in a single patient. | Cold Spring Harb Mol Case Stud | 2018 | 29440180 | PubTator, text mining | PubMed |
| The Smyd Family of Methyltransferases: Role in Cardiac and Skeletal Muscle Physiology and Pathology. | Curr Opin Physiol | 2018 | 29435515 | PubTator, text mining | PubMed |
| IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation. | Nat Commun | 2018 | 29422534 | PubTator, text mining | PubMed |
| Epigenetic editing: How cutting-edge targeted epigenetic modification might provide novel avenues for autoimmune disease therapy. | Clin Immunol | 2018 | 29421443 | PubTator, text mining | PubMed |
| Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing. | Oncotarget | 2018 | 29416665 | PubTator, text mining | PubMed |
| Contrasting roles of H3K4me3 and H3K9me3 in regulation of apoptosis and gemcitabine resistance in human pancreatic cancer cells. | BMC Cancer | 2018 | 29409480 | PubTator, text mining | PubMed |
| Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation. | Toxicol Appl Pharmacol | 2018 | 29391238 | PubTator, text mining | PubMed |
| Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers. | Elife | 2018 | 29384474 | PubTator, text mining | PubMed |
| Histone Methyltransferase Setd7 Regulates Nrf2 Signaling Pathway by Phenethyl Isothiocyanate and Ursolic Acid in Human Prostate Cancer Cells. | Mol Nutr Food Res | 2018 | 29383876 | PubTator, text mining | PubMed |
| Epigenetic features of human telomeres. | Nucleic Acids Res | 2018 | 29361030 | PubTator, text mining | PubMed |
| Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure. | J Biol Eng | 2018 | 29344085 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6839/papers?page=84